Concepedia

Publication | Closed Access

A RANDOMIZED MULTICENTER TRIAL OF THE ANTI-ICAM-1 MONOCLONAL ANTIBODY (ENLIMOMAB) FOR THE PREVENTION OF ACUTE REJECTION AND DELAYED ONSET OF GRAFT FUNCTION IN CADAVERIC RENAL TRANSPLANTATION

DOI

165

Citations

32

References

1999

Year

K. Salmela, Lars Wramner, Henrik Ekberg, I. Häuser, ystein Bentdal, Lars‐Eric Lins, Helena Isoniemi, Lars B ckman, Nils H. Persson, Hans–Hellmut Neumayer,
Transplantation

Abstract

Short term enlimomab induction therapy after renal transplantation did not reduce the rate of acute rejection or DGF.

References

YearCitations

Page 1